577 related articles for article (PubMed ID: 27419905)
21. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
[TBL] [Abstract][Full Text] [Related]
22. Low-Density Lipoprotein Cholesterol Goal Attainment Rates by Initial Statin Monotherapy Among Patients With Dyslipidemia and High Cardiovascular Risk in Japan - A Retrospective Database Analysis.
Umeda T; Hayashi A; Harada A; Okuyama K; Baxter CA; Tokita S; Teramoto T
Circ J; 2018 May; 82(6):1605-1613. PubMed ID: 29628458
[TBL] [Abstract][Full Text] [Related]
23. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
Wong ND; Chuang J; Zhao Y; Rosenblit PD
J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
[TBL] [Abstract][Full Text] [Related]
24. Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER).
Kawada-Watanabe E; Ogawa H; Koyanagi R; Arashi H; Yamaguchi J; Matsui K; Hagiwara N
J Cardiol; 2017 Mar; 69(3):536-541. PubMed ID: 27349705
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets.
Toth PP; Grabner M; Punekar RS; Quimbo RA; Cziraky MJ; Jacobson TA
Atherosclerosis; 2014 Aug; 235(2):585-91. PubMed ID: 24956532
[TBL] [Abstract][Full Text] [Related]
26. Management of low-density lipoprotein cholesterol levels in South Africa: the International ChoLesterol management Practice Study (ICLPS).
Blom DJ; Raal F; Amod A; Naidoo P; Lai YE;
Cardiovasc J Afr; 2019 Jan/Feb 23; 30(1):15-23. PubMed ID: 30720848
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis.
Jones PH; Nair R; Thakker KM
J Am Heart Assoc; 2012 Dec; 1(6):e001800. PubMed ID: 23316314
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care.
Guglielmi V; Bellia A; Pecchioli S; Della-Morte D; Parretti D; Cricelli I; Medea G; Sbraccia P; Lauro D; Cricelli C; Lapi F
Atherosclerosis; 2017 Aug; 263():36-41. PubMed ID: 28599257
[TBL] [Abstract][Full Text] [Related]
29. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
Ferrières J; Rouyer MV; Lautsch D; Ashton V; Ambegaonkar BM; Brudi P; Gitt AK;
Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
[TBL] [Abstract][Full Text] [Related]
30. How to assess and manage cardiovascular risk associated with lipid alterations beyond LDL.
Averna M; Stroes E;
Atheroscler Suppl; 2017 Apr; 26():16-24. PubMed ID: 28434480
[TBL] [Abstract][Full Text] [Related]
31. Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention: Analysis of a large real practice database in Italy.
Presta V; Figliuzzi I; Miceli F; Coluccia R; Fogacci F; Cicero AFG; Ferrucci A; Borghi C; Volpe M; Tocci G;
Atherosclerosis; 2019 Jun; 285():40-48. PubMed ID: 31003091
[TBL] [Abstract][Full Text] [Related]
32. The A-SACT (Achievement in Singapore of Cholesterol Targets) study in patients with coronary heart disease.
Ho KT; Chin KW; Ng KS; Alemao E; Rajagopalan S; Yin D
Am J Cardiovasc Drugs; 2006; 6(6):383-91. PubMed ID: 17192128
[TBL] [Abstract][Full Text] [Related]
33. Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments.
Yang YS; Lee SY; Kim JS; Choi KM; Lee KW; Lee SC; Cho JR; Oh SJ; Kim JH; Choi SH
Endocrinol Metab (Seoul); 2020 Jun; 35(2):367-376. PubMed ID: 32615721
[TBL] [Abstract][Full Text] [Related]
34. Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factors.
Breuker C; Clement F; Mura T; Macioce V; Castet-Nicolas A; Audurier Y; Boegner C; Morcrette E; Jalabert A; Villiet M; Avignon A; Sultan A
Int J Cardiol; 2018 Oct; 268():195-199. PubMed ID: 30041785
[TBL] [Abstract][Full Text] [Related]
35. Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study.
Kim HS; Wu Y; Lin SJ; Deerochanawong C; Zambahari R; Zhao L; Zhang Q; Yan P
Curr Med Res Opin; 2008 Jul; 24(7):1951-63. PubMed ID: 18547466
[TBL] [Abstract][Full Text] [Related]
36. Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry).
Spinler SA; Cziraky MJ; Willey VJ; Tang F; Maddox TM; Thomas T; Dueñas GG; Virani SS;
Am J Cardiol; 2015 Aug; 116(4):547-53. PubMed ID: 26089010
[TBL] [Abstract][Full Text] [Related]
37. Determinants of low-density lipoprotein cholesterol goal attainment: Insights from the CEPHEUS Pan-Asian Survey.
Wang KF; Chang CC; Wang KL; Wu CH; Chen LC; Lu TM; Lin SJ; Chiang CE
J Chin Med Assoc; 2014 Feb; 77(2):61-7. PubMed ID: 24332414
[TBL] [Abstract][Full Text] [Related]
38. Treatment Patterns and Lipid Profile in Patients with Familial Hypercholesterolemia in Japan.
Teramoto T; Kai T; Ozaki A; Crawford B; Arai H; Yamashita S
J Atheroscler Thromb; 2018 Jul; 25(7):580-592. PubMed ID: 29353825
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
40. Lipid-modifying therapy and attainment of cholesterol goals in Hungary: the return on expenditure achieved for lipid therapy (REALITY) study.
Paragh G; Márk L; Zámolyi K; Pados G; Ofner P
Clin Drug Investig; 2007; 27(9):647-60. PubMed ID: 17705573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
